LIM
JSPRW icon

Longfellow Investment Management’s Japer Therapeutics Warrants JSPRW Stock Holding History

Longfellow Investment Management’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-75,531
Closed -$112K – 538
2020
Q4 		$112K Hold
75,531
– – 0.01% 306
2020
Q3 		$89K Sell
75,531
-18,356
-20% -$18.6K 0.03% 100
2020
Q2 		$96K Buy
+93,887
New +$58.4K 0.03% 100

Other funds holding JSPRW

OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

Longfellow Investment Management's JSPRW Position: Q1 2021 in Review

Longfellow Investment Management sold out of Japer Therapeutics Warrants (JSPRW) in Q1 2021, closing a stake of 75,531 shares — an estimated $112K sold.

Longfellow Investment Management first reported a position in JSPRW in Q2 2020 and held it in 3 quarters. The position peaked at $112K in Q4 2020. 26 funds tracked by Wall St. Rank hold JSPRW as of Q1 2021.

  • Longfellow Investment Management reported no remaining Japer Therapeutics Warrants position as of Q1 2021 after selling out during the quarter.
  • Longfellow Investment Management sold 75,531 Japer Therapeutics Warrants shares in Q1 2021, an estimated $112K.
  • Longfellow Investment Management first reported a position in Japer Therapeutics Warrants in Q2 2020 and held it in 3 quarters.
  • Longfellow Investment Management's Japer Therapeutics Warrants position peaked at $112K in Q4 2020.
  • 26 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q1 2021.

Based on Longfellow Investment Management's 13F filing for Q1 2021, filed 17 May 2021.